Clinical Anesthesia Procedures
Octreotide (Sandostatin)
Indications
Upper GI tract bleeding and acute variceal hemorrhage.
Treatment of symptomatic carcinoid.
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Pino, Richard M., editor. "Octreotide (Sandostatin)." Clinical Anesthesia Procedures, 9th ed., Wolters Kluwer, 2019. Anesthesia Central, anesth.unboundmedicine.com/anesthesia/view/ClinicalAnesthesiaProcedures/728081/all/Octreotide__Sandostatin_.
Octreotide (Sandostatin). In: Pino RMR, ed. Clinical Anesthesia Procedures. Wolters Kluwer; 2019. https://anesth.unboundmedicine.com/anesthesia/view/ClinicalAnesthesiaProcedures/728081/all/Octreotide__Sandostatin_. Accessed November 20, 2024.
Octreotide (Sandostatin). (2019). In Pino, R. M. (Ed.), Clinical Anesthesia Procedures (9th ed.). Wolters Kluwer. https://anesth.unboundmedicine.com/anesthesia/view/ClinicalAnesthesiaProcedures/728081/all/Octreotide__Sandostatin_
Octreotide (Sandostatin) [Internet]. In: Pino RMR, editors. Clinical Anesthesia Procedures. Wolters Kluwer; 2019. [cited 2024 November 20]. Available from: https://anesth.unboundmedicine.com/anesthesia/view/ClinicalAnesthesiaProcedures/728081/all/Octreotide__Sandostatin_.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Octreotide (Sandostatin)
ID - 728081
ED - Pino,Richard M,
BT - Clinical Anesthesia Procedures
UR - https://anesth.unboundmedicine.com/anesthesia/view/ClinicalAnesthesiaProcedures/728081/all/Octreotide__Sandostatin_
PB - Wolters Kluwer
ET - 9
DB - Anesthesia Central
DP - Unbound Medicine
ER -
